(Reuters) - French drugmaker Genfit SA said on Thursday it will begin a late stage trial later this year of its lead treatment for a liver-destroying condition, saying it failed a midstage trial in ...

-- Initial positive data from Phase 1/2 clinical trial of PM359 in CGD provide clinical proof-of-concept for Prime Editing as a transformative gene editing technology -- -- On-track to file IND and/or ...

Ever-use of oral contraceptives was not tied to a higher risk of liver cancer in two large U.K. prospective cohorts. A systematic review and meta-analysis of 23 observational studies also found no ...

Many types of liver disease can develop for various reasons. These can include contracting a viral infection, consuming excess alcohol, and having a health condition that impairs the immune system.